1. Home
  2. RCKT vs DNUT Comparison

RCKT vs DNUT Comparison

Compare RCKT & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • DNUT
  • Stock Information
  • Founded
  • RCKT 1999
  • DNUT 1937
  • Country
  • RCKT United States
  • DNUT United States
  • Employees
  • RCKT N/A
  • DNUT N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • DNUT Food Chains
  • Sector
  • RCKT Health Care
  • DNUT Consumer Staples
  • Exchange
  • RCKT Nasdaq
  • DNUT Nasdaq
  • Market Cap
  • RCKT 328.6M
  • DNUT 578.7M
  • IPO Year
  • RCKT N/A
  • DNUT 2021
  • Fundamental
  • Price
  • RCKT $3.22
  • DNUT $3.13
  • Analyst Decision
  • RCKT Buy
  • DNUT Buy
  • Analyst Count
  • RCKT 13
  • DNUT 6
  • Target Price
  • RCKT $12.96
  • DNUT $6.22
  • AVG Volume (30 Days)
  • RCKT 5.7M
  • DNUT 3.6M
  • Earning Date
  • RCKT 11-06-2025
  • DNUT 11-06-2025
  • Dividend Yield
  • RCKT N/A
  • DNUT 3.37%
  • EPS Growth
  • RCKT N/A
  • DNUT N/A
  • EPS
  • RCKT N/A
  • DNUT N/A
  • Revenue
  • RCKT N/A
  • DNUT $1,538,841,000.00
  • Revenue This Year
  • RCKT N/A
  • DNUT N/A
  • Revenue Next Year
  • RCKT $108.43
  • DNUT $2.93
  • P/E Ratio
  • RCKT N/A
  • DNUT N/A
  • Revenue Growth
  • RCKT N/A
  • DNUT N/A
  • 52 Week Low
  • RCKT $2.19
  • DNUT $2.50
  • 52 Week High
  • RCKT $22.01
  • DNUT $12.68
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 49.27
  • DNUT 40.87
  • Support Level
  • RCKT $3.12
  • DNUT $2.95
  • Resistance Level
  • RCKT $3.30
  • DNUT $3.24
  • Average True Range (ATR)
  • RCKT 0.18
  • DNUT 0.18
  • MACD
  • RCKT -0.02
  • DNUT -0.04
  • Stochastic Oscillator
  • RCKT 20.03
  • DNUT 19.57

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.

Share on Social Networks: